Across TCGA pan-cancer cohorts, KRT18P29 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated KRT18P29 data layer.
The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher KRT18P29 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated KRT18P29 expression acts as an unfavorable survival marker, although some lineages such as THCA and KIRC show a favorable association.
SKCM, THCA, and LUAD are the cancer types where KRT18P29 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.